In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Uganda maintains diagnostic capacity efforts despite overcoming Marburg

This article was originally published in Clinica

Executive Summary

Efforts underway in Uganda to strengthen active surveillance of Marburg haemorrhagic fever (MHF) are continuing despite news that last month's human outbreak appears to be under control. Laboratory testing of suspected cases of MHF have confirmed the presence of the virus in the mineworker thought to be the so-called index case and in a close contact, the WHO announced on August 14. Also, the period of observation imposed on all extended contacts is coming to an end. However, surveillance efforts, including further testing of potential contacts, are being maintained pending confirmation of the reservoir of the virus, thought to be bats in a remote reserve in the west of the country. The WHO, US CDC and the African Field Epidemiology Network are among the bodies collaborating with the health ministry.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel